A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells
about
Vaccines in development against West Nile virusA recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virusDelivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro.C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins.A recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile Virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB/c mice.TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.West Nile virus: A re-emerging pathogen revisited.Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.Insect cell technology is a versatile and robust vaccine manufacturing platform.Technologies for the development of West Nile virus vaccines.Recombinant protein subunit vaccine synthesis in microbes: a role for yeast?A Brief Review of West Nile Virus Biology.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Industrial Large Scale of Suspension Culture of Insect Cells
P2860
Q26999702-9E782583-B304-42E1-859E-07C0B9930D6EQ28740740-E5907C75-D128-45B0-A177-9EAD7D94D76DQ33918636-BFED2859-5219-4D5E-9A85-B6FB73E280E0Q34540907-BB20FEF4-C07E-4313-92A2-F92D8D192EFAQ35129151-878E01EF-6B4A-410A-8B75-2C7C67514914Q37120117-6B1D8870-D838-434B-B63B-FB0BB7FAD8BCQ37195527-6E810545-CA32-4E59-893E-92269199D5E2Q37842337-94EC9868-240C-4680-9547-95F8A2EBD2D2Q37909427-ECA82C5F-FF66-4948-8458-33935DCCAEF1Q38269151-0BD46038-1C18-43CB-9A0B-087C314D16DEQ38306512-DF18AB26-4E62-4E6B-9469-3388C893BCAAQ38836534-E74E7662-3967-43B4-8195-C3CC9E1C5DA5Q38866173-80425987-513B-4497-9367-DAEBACAA3B32Q58753697-88FCC63B-85AD-4769-92A2-D1B8BA24F336
P2860
A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@ast
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@en
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@nl
type
label
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@ast
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@en
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@nl
prefLabel
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@ast
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@en
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@nl
P2093
P2860
P1433
P1476
A recombinant West Nile virus ...... era frugiperda expresSF+ cells
@en
P2093
Harald G Foellmer
John F Anderson
Joseph A Rininger
Karen Anthony
Nathalie Bonafé
Paul Kaplan
Raymond A Koski
Richard G Chubet
Sandra L Bushmich
Stacey Fader
P2860
P304
P356
10.1016/J.VACCINE.2008.10.046
P407
P577
2009-01-07T00:00:00Z